Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)

Clinical trial NCT00901849 · COMPLETED

Trial details

NCT number: NCT00901849
Sponsor: Roger Packer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Low-grade Gliomas

Start date: 2007-05-01
Primary completion: 2010-07-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.